Skip to main content
Premium Trial:

Request an Annual Quote

Enzo Biochem, Agilent Settle Patent Infringement Lawsuit

NEW YORK (GenomeWeb) – Agilent Technologies will pay Enzo Biochem $9 million to settle a patent infringement lawsuit between the companies, Enzo said today.

The suit alleged that Agilent had infringed on Enzo's U.S. Patent No. 7,064,197  for non-porous solid supports for fixed or immobilized nucleic acids. The legal action is more than a decade old — Enzo originally sued several companies, including PerkinElmer, Sigma-Aldrich, GE Healthcare, Affymetrix, Orchid Biosciences, Molecular Probes, and Roche, claiming the companies were infringing on eight different patents by selling certain reagent kits.

PerkinElmer settled with Enzo in June 2014 for $7 million, Siemens settled in July 2015 for an upfront payment of $9.5 million, Luminex settled in July 2015 for $7.1 million, and Affymetrix settled in October for $10 million.

In all, Enzo still has eight infringement cases pending before the court, the company said in a statement.

The Scan

Shape of Them All

According to BBC News, researchers have developed a protein structure database that includes much of the human proteome.

For Flu and More

The Wall Street Journal reports that several vaccine developers are working on mRNA-based vaccines for influenza.

To Boost Women

China's Ministry of Science and Technology aims to boost the number of female researchers through a new policy, reports the South China Morning Post.

Science Papers Describe Approach to Predict Chemotherapeutic Response, Role of Transcriptional Noise

In Science this week: neural network to predict chemotherapeutic response in cancer patients, and more.